Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone (original) (raw)

The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia

Schizophrenia Bulletin, 2000

Clozapine, Olanzapine, or Typical Antipsychotics for Alcohol Use Disorder in Patients With Schizophrenia

Journal of Dual Diagnosis, 2008

Clozapine Use and Relapses of Substance Use Disorder Among Patients With Co-occurring Schizophrenia and Substance Use Disorders

Gregory McHugo

Schizophrenia Bulletin, 2005

View PDFchevron_right

Substance abuse and schizophrenia: Pharmacotherapeutic intervention

Mary Brunette

Journal of Substance Abuse Treatment, 2008

View PDFchevron_right

Antipsychotic Agents for the Treatment of Substance Use Disorders in Patients With and Without Comorbid Psychosis

Emmanuel Stip

Journal of Clinical Psychopharmacology, 2010

View PDFchevron_right

Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders

Mary Brunette

Current Addiction Reports, 2014

View PDFchevron_right

Comorbid Alcohol, Cannabis, and Cocaine Use Disorders in Schizophrenia: Epidemiology, Consequences, Mechanisms, and Treatment

Peter H Addy

FOCUS, 2012

View PDFchevron_right

Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine

Durk Wiersma

Journal of Psychopharmacology, 2012

View PDFchevron_right

Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study

Dick Veltman

Schizophrenia Research, 2017

View PDFchevron_right

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: Results from the CATIE study

Ryan Wagner

Schizophrenia Research, 2008

View PDFchevron_right

Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity. Can J Psychiatry

Cecilio Alamo

Canadian journal of psychiatry. Revue canadienne de psychiatrie

View PDFchevron_right

Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis

maxine gossell-williams

Frontiers in pharmacology, 2018

View PDFchevron_right

Clozapine treatment in patients with prior substance abuse

Robert Conley

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003

View PDFchevron_right

Long-Acting Injectable Risperidone Compared With Zuclopenthixol in the Treatment of Schizophrenia With Substance Abuse Comorbidity

Gabriel Rubio

2006

View PDFchevron_right

Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency

Zoltan Makkos, Lilla Fejes

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011

View PDFchevron_right

Risperidone versus zuclopenthixol in the treatment od schizophrenia with substance abuse comorbidity: a longterm randomized, controlled, crossover study

Tomas Palomo

European Journal of Psychiatry, 2006

View PDFchevron_right

Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia – a nationwide, register-based cohort study

Mette Karlsen

Psychological medicine, 2024

View PDFchevron_right

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial

Emmanuel Stip

Current Medical Research and Opinion, 2006

View PDFchevron_right

Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis

enrico foglia

Psychological Medicine, 2017

View PDFchevron_right

Clozapine Alone versus Clozapine and Risperidone with Refractory Schizophrenia

Allen Thornton

New England Journal of Medicine, 2006

View PDFchevron_right

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

jeffrey lieberman

Schizophrenia research, 2004

View PDFchevron_right

Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study

Sercan Karabulut

CNS drugs, 2016

View PDFchevron_right

The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study

Dick Veltman

Journal of Psychopharmacology, 2014

View PDFchevron_right

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

LESLIE CITROME

Innovations in clinical neuroscience, 2019

View PDFchevron_right

Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism?

Mary Brunette

Current Psychiatry Reports, 2005

View PDFchevron_right

Clozapine Alone versus Clozapine and Risperidone for Refractory Schizophrenia

Ric Procyshyn

New England Journal of Medicine, 2006

View PDFchevron_right

Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case–Control Trial with Quetiapine

Emmanuel Stip

Frontiers in Psychiatry, 2011

View PDFchevron_right

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone (original) (raw)

Related papers